Journal
JOURNAL OF TRANSLATIONAL MEDICINE
Volume 19, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12967-021-03165-x
Keywords
Metabolism; CAR-T; Immunotherapy; Glycolysis; OXPHOS
Categories
Funding
- General Project of National Natural Science Foundation of China [81970180]
- Key Science and Technology Support Project of Tianjin Science and Technology Bureau [20YFZCSY00800]
- Tianjin Key Medical Discipline (Specialty) Construction Project
Ask authors/readers for more resources
CAR-T cell therapy has shown significant efficacy in treating hematological malignancies, but faces challenges in solid tumor therapy. Researchers have been focusing on improving the metabolic adaptability and antitumor activity of CAR-T cells, leading to some breakthroughs in recent years.
Chimeric antigen receptor T cell (CAR-T cell) therapy is a relatively new, effective, and rapidly evolving therapeutic for adoptive immunotherapies. Although it has achieved remarkable effect in hematological malignancies, there are some problems that remain to be resolved. For example, there are high recurrence rates and poor efficacy in solid tumors. In this review, we first briefly describe the metabolic re-editing of T cells and the changes in metabolism during the preparation of CAR-T cells. Furthermore, we summarize the latest developments and newest strategies to improve the metabolic adaptability and antitumor activity of CAR-T cells in vitro and in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available